Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Stomach Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Glioblastoma 1Drug-Related Side Effects and Adverse Reactions 1Depression 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anxiety Disorders 1All Solid Tumors 1

Interventions

Therapeutics 1Psychiatric Rehabilitation 1Psilocybin 1Pharmaceutical Preparations 1Niacinamide 1Niacin 1Exercise Therapy 1Coping Skills 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Depression × Pharmaceutical Preparations × Clear all
NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡